Vasodilator drugs in the treatment of hypertension.
D000284:Administration, Oral; D002302:Cardiac Output / Q000187:drug effects; D003981:Diazoxide / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005292:Ferricyanides / Q000008:administration & dosage / Q000627:therapeutic use; D006146:Guanidines / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007263:Infusions, Parenteral; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D008914:Minoxidil / Q000008:administration & dosage / Q000627:therapeutic use; D009569:Nitric Oxide / Q000008:administration & dosage / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
D004232:Diuretics; D005292:Ferricyanides; D006146:Guanidines; D014665:Vasodilator Agents; D006830:Hydralazine; D009569:Nitric Oxide; D008914:Minoxidil; D011433:Propranolol; D003981:Diazoxide